Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Serfaty

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Non-transfusional and non-intravenous drug addiction related transmission of hepatitis C virus]L Serfaty
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Results of treatment of hepatitis C with interferon alone or combined with other drugs]L Serfaty
Gastroenterologie Clinique Et Biologique|April 7, 2009
[Nonalcoholic fatty liver disease: hypotheses and established concepts]L Serfaty
Diabetes & Metabolism|February 7, 2009
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosisL Serfaty, M Lemoine
Bulletin De L'Academie Nationale De Medecine|June 1, 1996
[Prevention and treatment of hepatitis C]R Poupon, L Serfaty
Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivativesL Serfaty, R Poupon
Bone Marrow Transplantation|January 31, 2006
Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantationL Fouillard, L Serfaty, J Gozlan
Gastroenterologie Clinique Et Biologique|May 1, 1995
[What are the non transfusional modes of transmission of hepatitis C virus?]L Serfaty, P Mavier, D Valla
Clinics and Research in Hepatology and Gastroenterology|July 12, 2011
First European Young Hepatologist Workshop: topics and advancesL Serfaty, L Castera, P Marcellin
Gastroenterologie Clinique Et Biologique|July 9, 2010
Ursodeoxycholic acid and chemoprevention of colorectal cancerL Serfaty, M Bissonnette, R Poupon
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|July 10, 1999
[Non-transfusional and non-intravenous drug addiction related transmission of hepatitis C virus]L Serfaty
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Results of treatment of hepatitis C with interferon alone or combined with other drugs]L Serfaty
Gastroenterologie Clinique Et Biologique|April 7, 2009
[Nonalcoholic fatty liver disease: hypotheses and established concepts]L Serfaty
Diabetes & Metabolism|February 7, 2009
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosisL Serfaty, M Lemoine
Bulletin De L'Academie Nationale De Medecine|June 1, 1996
[Prevention and treatment of hepatitis C]R Poupon, L Serfaty
Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivativesL Serfaty, R Poupon
Bone Marrow Transplantation|January 31, 2006
Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantationL Fouillard, L Serfaty, J Gozlan
Gastroenterologie Clinique Et Biologique|May 1, 1995
[What are the non transfusional modes of transmission of hepatitis C virus?]L Serfaty, P Mavier, D Valla
Clinics and Research in Hepatology and Gastroenterology|July 12, 2011
First European Young Hepatologist Workshop: topics and advancesL Serfaty, L Castera, P Marcellin
Gastroenterologie Clinique Et Biologique|July 9, 2010
Ursodeoxycholic acid and chemoprevention of colorectal cancerL Serfaty, M Bissonnette, R Poupon
Pageof 5